Yuechun Shen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuechun Shen has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Weidong Zhang
From the *Department of Radiology, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, PR China; †Department of Radiology, Cancer Center, Sun Yat-sen University, Guangzhou, PR China; ‡Department of Radiology, The People Hospital of Dongguan, Dongguan, PR China; and §Departments of Pathology and ∥Internal Medicine, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, PR China
2 shared publicationsXinchun Li
Department of Radiology, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, PR China
2 shared publications- Ai-Lan Chen
Department of Cardiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
1 shared publication - Caiwen Ou
Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, China
1 shared publication Chaochen Zhao
Department of Hepatobiliary Surgery The First Affiliated Hospital of Guangzhou Medical College Guangzhou China
1 shared publicationCongpeng Sun
From the *Department of Radiology, The First Affiliated Hospital of Guangzhou Medical College; †Department of Radiology, Cancer Center, Sun Yat-sen University; ‡Department of Radiology, The Second Affiliated Hospital of Sun Yat-sen University; and §Department of Internal Medicine, The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, P.R. China
1 shared publication
Latest Publications
- Open Access
- 17 November 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 1-10
Trimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction
Metabolism remodeling has been recognized as an early event following cardiac pressure overload. However, its temporal association with ventricular hypertrophy has not been confirmed. Moreover, whether trimetazidine could favorably affect this process also needs to be determined. The aim of the study was to explore the temporal changes of myocardial metabolism remodeling following pressure-overload induced ventricular hypertrophy and the potential favorable effect of trimetazidine on myocardial metabolism remodeling. A rat model of abdominal aortic constriction (AAC)-induced cardiac pressure overload was induced. These rats were grouped as the AAC (no treatment) or TMZ group according to whether oral trimetazidine (TMZ, 40 mg/kg/d, for 5 days) was administered. Changes in cardiac structures were sequentially evaluated via echocardiography. The myocardial ADP/ATP ratio was determined to reflect the metabolic status, and changes in serum neuropeptide Y systems were evaluated. Myocardial metabolic disorder was acutely induced as evidenced by an increased ADP/ATP ratio within 7 days of AAC before the morphological changes in the myocardium, accompanied by up-regulation of serum oxidative stress markers and expression of fetal genes related to hypertrophy. Moreover, the serum NPY and myocardial NPY-1R, 2R, and 5R levels were increased within the acute phase of AAC-induced cardiac pressure overload. Pretreatment with TMZ could partly attenuate myocardial energy metabolic homeostasis, decrease serum levels of oxidative stress markers, attenuate the induction of hypertrophy-related myocardial fetal genes, inhibit the up-regulation of serum NPY levels, and further increase the myocardial expression of NPY receptors. Cardiac metabolic remodeling is an early change in the myocardium before the presence of typical morphological ventricular remodeling following cardiac pressure overload, and pretreatment with TMZ may at least partly reverse the acute metabolic disturbance, perhaps via regulation of the NPY system.
- 17 November 2016
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 16 (1) , 1-10
Open AccessTrimetazidine attenuates pressure overload-induced early cardiac energy dysfunction via regulation of neuropeptide Y system in a rat model of abdominal aortic constriction
Metabolism remodeling has been recognized as an early event following cardiac pressure overload. However, its temporal association with ventricular hypertrophy has not been confirmed. Moreover, whether trimetazidine could favorably affect this process also needs to be determined. The aim of the study was to explore the temporal changes of myocardial metabolism remodeling following pressure-overload induced ventricular hypertrophy and the potential favorable effect of trimetazidine on myocardial metabolism remodeling. A rat model of abdominal aortic constriction (AAC)-induced cardiac pressure overload was induced. These rats were grouped as the AAC (no treatment) or TMZ group according to whether oral trimetazidine (TMZ, 40 mg/kg/d, for 5 days) was administered. Changes in cardiac structures were sequentially evaluated via echocardiography. The myocardial ADP/ATP ratio was determined to reflect the metabolic status, and changes in serum neuropeptide Y systems were evaluated. Myocardial metabolic disorder was acutely induced as evidenced by an increased ADP/ATP ratio within 7 days of AAC before the morphological changes in the myocardium, accompanied by up-regulation of serum oxidative stress markers and expression of fetal genes related to hypertrophy. Moreover, the serum NPY and myocardial NPY-1R, 2R, and 5R levels were increased within the acute phase of AAC-induced cardiac pressure overload. Pretreatment with TMZ could partly attenuate myocardial energy metabolic homeostasis, decrease serum levels of oxidative stress markers, attenuate the induction of hypertrophy-related myocardial fetal genes, inhibit the up-regulation of serum NPY levels, and further increase the myocardial expression of NPY receptors. Cardiac metabolic remodeling is an early change in the myocardium before the presence of typical morphological ventricular remodeling following cardiac pressure overload, and pretreatment with TMZ may at least partly reverse the acute metabolic disturbance, perhaps via regulation of the NPY system.
- 20 November 2012
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (12) , 1783-1789
Autoimmune cholangitis and cholangiocarcinoma
Autoimmune cholangitis, immunoglobulin G4‐associated cholangitis (IAC), is a part of multiorgan IgG4‐related systemic disease, which was recognized as a new clinicopathological entity in recent years. IAC is defined as a biliary stricture that responds to steroid therapy, frequently is associated with other fibrosing conditions, especially autoimmune pancreatitis and is characterized by elevation of IgG4 in serum and infiltration of IgG4 positive plasma cells in bile ducts. Since IAC shares a number of clinical, biochemical, and imaging features with cholangiocarcinoma (CCA), it is often misdiagnosed as CCA, and unnecessary surgery was performed. In this compact review, we clarify the disease of IAC, summarize criteria for diagnosis of IAC, discuss the role of CA 19‐9, and provide key information to differentiate diagnosis of IAC from CCA. IAC should be highly suspected in unexplained biliary stricture associated with increased IgG4 (in serum especially in bile) and other organ involvement (kidney, retroperitoneum etc. especially pancreas in which there are abundant IgG4‐positive plasmocytes infiltration). Correct diagnosis of IAC will avoid unnecessary surgery because IAC responds well to steroid therapy. In a word, increased IgG4 levels, other organ involvement and response to steroids are keys to distinguishing IAC from CCA.
- 20 November 2012
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (12) , 1783-1789
Autoimmune cholangitis and cholangiocarcinoma
Autoimmune cholangitis, immunoglobulin G4‐associated cholangitis (IAC), is a part of multiorgan IgG4‐related systemic disease, which was recognized as a new clinicopathological entity in recent years. IAC is defined as a biliary stricture that responds to steroid therapy, frequently is associated with other fibrosing conditions, especially autoimmune pancreatitis and is characterized by elevation of IgG4 in serum and infiltration of IgG4 positive plasma cells in bile ducts. Since IAC shares a number of clinical, biochemical, and imaging features with cholangiocarcinoma (CCA), it is often misdiagnosed as CCA, and unnecessary surgery was performed. In this compact review, we clarify the disease of IAC, summarize criteria for diagnosis of IAC, discuss the role of CA 19‐9, and provide key information to differentiate diagnosis of IAC from CCA. IAC should be highly suspected in unexplained biliary stricture associated with increased IgG4 (in serum especially in bile) and other organ involvement (kidney, retroperitoneum etc. especially pancreas in which there are abundant IgG4‐positive plasmocytes infiltration). Correct diagnosis of IAC will avoid unnecessary surgery because IAC responds well to steroid therapy. In a word, increased IgG4 levels, other organ involvement and response to steroids are keys to distinguishing IAC from CCA.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (4) , 462-468
Computed Tomographic and Pathological Findings of Dermatofibrosarcoma Protuberans
Objective The aim of the study was to investigate the computed tomographic (CT) and pathological findings of dermatofibrosarcoma protuberans to improve the awareness and understanding of the tumors from aspect of CT images. Methods The CT findings of 16 cases (17 tumors) with dermatofibrosarcoma protuberans confirmed by pathological findings were retrospectively selected. Fourteen cases were primary dermatofibrosarcoma protuberans, 2 cases were recurrent tumors. Thirteen patients had CT plain and enhanced scans, 1 patient had direct enhanced CT scan, 2 patients had only unenhanced scan. Images of the tumors were analyzed and compared with pathological results. Results Of the 16 cases (17 tumors total), 9 cases were on the trunk, 7 cases were on the head and the neck; 15 cases appeared as solitary isohypodense, ovoid, or round mass at the cutaneous and subcutaneous tissue, 1 case demonstrated 2 isodense masses on unenhanced CT images. The mean diameter of tumors was 4.0 cm, and the depth was 1.7 cm. The margin was well defined (n = 15 [88.2%]) or ill defined (n = 2 [11.8%]). Fifteen tumors revealed moderate or marked homogeneous (n = 12 [80%], smaller lesion, diameter <5 cm) or heterogeneous (n = 3 [20%], larger lesion, diameter ≥5 cm) enhancement on enhanced CT with intratumoral nonenhancement areas, which indicated intratumoral necrotic and cystic degeneration areas. No calcifications and metastasis were found. The histological examinations revealed large amounts of uniform spindle cells, which were arranged in “storiform” pattern. Immunohistochemical analysis revealed samples positive for CD34 and vimentin. Conclusion The common imaging findings of dermatofibrosarcoma protuberans include a solitary, superficial, subcutaneous solid mass, various homogenous or heterogeneous enhancements due to degenerative areas. Computed tomographic scan is helpful to detect the size, location, depth and range of this tumor.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (4) , 462-468
Computed Tomographic and Pathological Findings of Dermatofibrosarcoma Protuberans
Objective The aim of the study was to investigate the computed tomographic (CT) and pathological findings of dermatofibrosarcoma protuberans to improve the awareness and understanding of the tumors from aspect of CT images. Methods The CT findings of 16 cases (17 tumors) with dermatofibrosarcoma protuberans confirmed by pathological findings were retrospectively selected. Fourteen cases were primary dermatofibrosarcoma protuberans, 2 cases were recurrent tumors. Thirteen patients had CT plain and enhanced scans, 1 patient had direct enhanced CT scan, 2 patients had only unenhanced scan. Images of the tumors were analyzed and compared with pathological results. Results Of the 16 cases (17 tumors total), 9 cases were on the trunk, 7 cases were on the head and the neck; 15 cases appeared as solitary isohypodense, ovoid, or round mass at the cutaneous and subcutaneous tissue, 1 case demonstrated 2 isodense masses on unenhanced CT images. The mean diameter of tumors was 4.0 cm, and the depth was 1.7 cm. The margin was well defined (n = 15 [88.2%]) or ill defined (n = 2 [11.8%]). Fifteen tumors revealed moderate or marked homogeneous (n = 12 [80%], smaller lesion, diameter <5 cm) or heterogeneous (n = 3 [20%], larger lesion, diameter ≥5 cm) enhancement on enhanced CT with intratumoral nonenhancement areas, which indicated intratumoral necrotic and cystic degeneration areas. No calcifications and metastasis were found. The histological examinations revealed large amounts of uniform spindle cells, which were arranged in “storiform” pattern. Immunohistochemical analysis revealed samples positive for CD34 and vimentin. Conclusion The common imaging findings of dermatofibrosarcoma protuberans include a solitary, superficial, subcutaneous solid mass, various homogenous or heterogeneous enhancements due to degenerative areas. Computed tomographic scan is helpful to detect the size, location, depth and range of this tumor.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (1) , 46-53
Imaging Features and Pathologic Characteristics of Ovarian Thecoma
Objective To analyze the imaging findings of ovarian thecoma and to better understand the tumor features based on aspect of computed tomography and magnetic resonance images. Methods Nineteen ovarian thecomas confirmed by histopathologic examination were analyzed retrospectively. Image characteristics were analyzed and compared with those of the pathologic features. Results The mean diameter of tumors was 9.6 cm. The masses were well defined (n = 17) or ill defined (n = 2) and appeared solid with cystic areas (n = 11), entirely solid (n = 4), or cystic with solid components (n = 4). On T2-weighted/spectral adiabatic inversion recovery (T2WI/SPAIR) images, 12 cases appeared isointense or slightly hyperintense. Of the 12 cases, 8 had patchy hypersignal areas. On computed tomographic images, 7 cases showed hypodensity or isodensity. All tumors exhibited mild enhancement. On pathologic examination, the tumor was composed of spindle cells with a moderate amount of cytoplasm. Conclusion Imaging manifestations of ovarian thecoma are various and nonspecific. However, a large, well-defined mildly enhanced solid mass with cystic areas and especially isointense or slightly hyperintense on T2WI/SPAIR sequence in pelvic cavity may suggest the diagnosis of ovarian thecoma.
- 1 January 2012
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 36 (1) , 46-53
Imaging Features and Pathologic Characteristics of Ovarian Thecoma
Objective To analyze the imaging findings of ovarian thecoma and to better understand the tumor features based on aspect of computed tomography and magnetic resonance images. Methods Nineteen ovarian thecomas confirmed by histopathologic examination were analyzed retrospectively. Image characteristics were analyzed and compared with those of the pathologic features. Results The mean diameter of tumors was 9.6 cm. The masses were well defined (n = 17) or ill defined (n = 2) and appeared solid with cystic areas (n = 11), entirely solid (n = 4), or cystic with solid components (n = 4). On T2-weighted/spectral adiabatic inversion recovery (T2WI/SPAIR) images, 12 cases appeared isointense or slightly hyperintense. Of the 12 cases, 8 had patchy hypersignal areas. On computed tomographic images, 7 cases showed hypodensity or isodensity. All tumors exhibited mild enhancement. On pathologic examination, the tumor was composed of spindle cells with a moderate amount of cytoplasm. Conclusion Imaging manifestations of ovarian thecoma are various and nonspecific. However, a large, well-defined mildly enhanced solid mass with cystic areas and especially isointense or slightly hyperintense on T2WI/SPAIR sequence in pelvic cavity may suggest the diagnosis of ovarian thecoma.